DexCom's Q3 results showed disappointing 2% revenue growth and a 26% decline in operating income. Click here to read my DXCM ...

Signos' platform works with Dexcom's G6 CGM and the newer G7 CGM ... I'm generally fine around needles, though I tend to look away if I have to get a shot at the doctor's office. The CGM's needle is ...

Dexcom's G7 product is significantly less expensive, offer a thinner profile, and faster warm-up time than G6. Medicare's decision to reimburse for the G6 and G7 is a favorable development for ...

A class action lawsuit was filed against DexCom, Inc. (DXCM ... the gross margin guidance reflected the conversion from the G6 to the G7 CGM model. Additionally, during the Q1 FY24 report ...

Sticking on a Stelo and Dexcom CGM basics The Stelo glucose monitor is made by Dexcom, one of the two major diabetes care ...

In a report released today, Joanne Wuensch from Citi maintained a Buy rating on Dexcom (DXCM – Research Report). The company’s ...

Dexcom (DXCM – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst yesterday. Analyst William ...

DexCom ( NASDAQ:DXCM ) Third Quarter 2024 Results Key Financial Results Revenue: US$994.2m (up 2.0% from 3Q 2023). Net... Dexcom stock closed in the red on Friday after the diabetes devices player ...

Artisan Mid Cap Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that engages in the ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...